News
March 28, 2019

Boston Globe Highlights Eskenazi Health, Regenstrief Researcher in Article about New Program at Massachusetts General Hospital

The Boston Globe featured an Eskenazi Health program led by Regenstrief Research Scientist Malaz Boustani, M.D., in an article describing the launch of a new Massachusetts General Hospital program to support primary care physicians in caring for older patients living with dementia.

The program is similar to the one at Sandra Eskenazi Center for Brain Care Innovation, led by Dr. Boustani, who is also the director for the Center for Health Innovation and Implementation Science.

The collaborative dementia care program was started by Eskenazi more than a decade ago. The system trains and employs community health workers who meet with families of people with dementia. The workers help those families address difficulties, actively work to reduce stress and keep track of how the families are functioning.

Massachusetts General Hospital is launching a pilot program where a dementia care team will be embedded in primary care practices at the hospital. The specialists and social workers can help those doctors when they suspect one of their patients may have dementia.

A recent survey by the Alzheimer’s Association® found that less than half of physicians reported assessing their older patients for cognitive impairment.

“I feel their pain. The primary care doctors, they don’t have the resources, they don’t have the time,” Dr. Boustani told the Globe. He believes that programs like the one at Eskenazi can lead to better health and quality of life for people with dementia and their families.

Dr. Boustani also is a professor at Indiana University School of Medicine and the director for the Center for Health Innovation and Implementation Science.

Read the entire Boston Globe Article here.

  • Dr. Malaz Boustani

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released